PPARGC1A and non-small cell lung carcinoma: In addition, PGC1α elevates the mitochondrial oxidative phosphorylation in non-small cell lung cancer cisplatin-resistant cells to resist reactive oxygen species (ROS) damage caused by cisplatin and promotes the drug resistance of cancer cells [10].